These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5464498)

  • 81. Pyridostigmine levels in myasthenia gravis.
    Kornfeld P; Mittag T; Genkins G; Papatestas AE; Horowitz SH
    Neurology; 1977 Nov; 27(11):1099. PubMed ID: 563008
    [No Abstract]   [Full Text] [Related]  

  • 82. [A curable muscular disease].
    Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1976 Jan; 120(5):181-4. PubMed ID: 1250450
    [No Abstract]   [Full Text] [Related]  

  • 83. [Myasthenia gravis in an active 48-year-old woman, demonstrated clinically, electrically and serologically, well tolerated for 30 years, thanks to Prostigmine and Mestinon. Some theoretical and practical problems].
    Chesni Y
    Rev Med Suisse Romande; 1979 May; 99(5):289-90. PubMed ID: 119291
    [No Abstract]   [Full Text] [Related]  

  • 84. Congenital myasthenia gravis. The clinical spectrum. A practical approach to diagnosis and treatment.
    Dooley JM; Writer H; Gibson EJ; MacSween J
    Clin Pediatr (Phila); 1988 Dec; 27(12):575-8. PubMed ID: 3191649
    [No Abstract]   [Full Text] [Related]  

  • 85. Pseudomyopia as a presenting sign in ocular myasthenia gravis.
    Romano PE; Stark WJ
    Am J Ophthalmol; 1973 May; 75(5):872-5. PubMed ID: 4706420
    [No Abstract]   [Full Text] [Related]  

  • 86. [Isolated proximal muscular weakness disclosing myasthenic syndrome].
    Azulay JP; Pouget J; Figarella-Branger D; Colamarino R; Pellissier JF; Serratrice G
    Rev Neurol (Paris); 1994; 150(5):377-81. PubMed ID: 7878325
    [TBL] [Abstract][Full Text] [Related]  

  • 87. An unusual presentation of myasthenia gravis.
    Chijoke A; Ogunmodele JA
    West Afr J Med; 2009; 28(6):391-3. PubMed ID: 20486100
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Seronegative myasthenia gravis associated with atonic urinary bladder and accommodative insufficiency.
    Matsui M; Enoki M; Matsui Y; Oono S; Ohta M; Suenaga A; Kuroda Y
    J Neurol Sci; 1995 Nov; 133(1-2):197-9. PubMed ID: 8583227
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Plasma pyridostigmine levels in patients with myasthenia gravis.
    Calvey TN; Chan K
    Clin Pharmacol Ther; 1977 Feb; 21(2):187-93. PubMed ID: 837637
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Seronegative myasthenia gravis with bladder dysfunction.
    Marouani I; Kraoua I; Benrhouma H; Rebai I; Rouissi A; Koubaa S; Turki I; Dziri C; Gouider-Khouja N
    Rev Neurol (Paris); 2012 Mar; 168(3):299-300. PubMed ID: 22365108
    [No Abstract]   [Full Text] [Related]  

  • 91. An unusual case of myasthenia gravis in an elderly patient with severe muscular atrophy.
    Vellodi C; Tallis RC
    Gerontology; 1988; 34(4):209-11. PubMed ID: 3181772
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Myasthenia gravis with features of the myasthenic syndrome. An investigation with electrophysiologic methods including single-fiber electromyography.
    Schwartz MS; Stålberg E
    Neurology; 1975 Jan; 25(1):80-4. PubMed ID: 1167410
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Discordant thymectomy in identical twins concordant for myasthenia gravis.
    Riggs KR; Gutmann L; Riggs JE
    Ann Intern Med; 2011 Oct; 155(7):478-9. PubMed ID: 21969350
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Advantages of pyridostigmine bromide (mestinon) and edrophonium chloride (tensilon) in the treatment of transitory myasthenia gravis in the neonatal period.
    MOORE H
    N Engl J Med; 1955 Dec; 253(24):1075-6. PubMed ID: 13272842
    [No Abstract]   [Full Text] [Related]  

  • 95. Treatment of myasthenia gravis with pyridostigmine.
    Grogan WA
    Arch Neurol; 1987 Oct; 44(10):995-6. PubMed ID: 3632385
    [No Abstract]   [Full Text] [Related]  

  • 96. Respiratory arrest in myasthenia gravis with colistimethate therapy.
    Decker DA; Fincham RW
    Arch Neurol; 1971 Aug; 25(2):141-4. PubMed ID: 5571015
    [No Abstract]   [Full Text] [Related]  

  • 97. Myasthenia gravis unmasked by imatinib.
    Kopp CR; Jandial A; Mishra K; Sandal R; Malhotra P
    Br J Haematol; 2019 Feb; 184(3):321. PubMed ID: 30203413
    [No Abstract]   [Full Text] [Related]  

  • 98. Pseudointernuclear ophthalmoplegia as a presenting feature of ocular myasthenia gravis.
    Nijsse B; Bettink MW; Neuteboom RF
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24928935
    [No Abstract]   [Full Text] [Related]  

  • 99. Myasthenia gravis, an often overlooked disease in the geriatric group.
    Stern FH
    J Am Geriatr Soc; 1966 Oct; 14(10):1052-7. PubMed ID: 5924629
    [No Abstract]   [Full Text] [Related]  

  • 100. Respiratory failure in myasthenia gravis and negative pressure support.
    Chisakuta A; Tasker RC
    Pediatr Neurol; 1998 Sep; 19(3):225-6. PubMed ID: 9806142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.